This inventor holds 3 USPTO granted patents. Top assignees: Gilead Sciences, Inc., Isis Pharmaceuticals, Inc., Other. Active years: 1992-2001.
Company Filing History:
1 out of 946 
1 out of 1,035 
1 out of 834,307 Years Active: 1992-2001
Title: The Innovative Contributions of Inventor Sylvia Wu
Introduction
Sylvia Wu is a notable inventor located in Castro Valley, California. With an impressive portfolio that includes three patents, her work focuses on groundbreaking methods for the production of oligonucleotides. Her contributions to biotechnology reflect her commitment to advancing the field through innovative synthesis techniques.
Latest Patents
Sylvia Wu's latest patents include significant advancements in the production of oligonucleotides and their associated analogs. One of her notable inventions describes methods for synthesizing oligonucleotides using functionalized organic polymeric supports. The invention highlights a process that allows for high degrees of substitution while effectively mitigating sluggish kinetics and low conversion rates typically associated with solid support syntheses. By employing these methods, functionalized supports can achieve over 98% conversion levels per nucleotide coupling cycle, resulting in unprecedented quantities of isolated oligonucleotide per gram of solid support.
Another patent centers around monomethoxytrityl protected oligonucleotides bound to solid supports. This invention similarly emphasizes the benefits of high substitution levels and efficient conversion rates, making it a vital advancement in the synthesis of oligonucleotides.
Career Highlights
Throughout her career, Sylvia Wu has contributed significantly to biotechnology through her innovative research. Her tenure includes experience at prestigious organizations such as Gilead Sciences, Inc., where she has worked to pioneer new methodologies in the field of oligonucleotide synthesis.
Collaborations
In her professional journey, Sylvia has collaborated with esteemed colleagues, including Brian C. Froehler and Kenneth M. Kent. These partnerships have enabled her to leverage diverse expertise and further enhance her contributions to the field.
Conclusion
Sylvia Wu's inventive spirit and dedication to advancing oligonucleotide synthesis have made her a key figure in biotechnology. Through her patents, she has provided innovation that not only addresses existing challenges but also paves the way for future discoveries in the field, solidifying her place as a leading inventor.